Ventas, Inc. (VTR), headquartered in Chicago, Illinois, is a leading real estate investment trust (REIT) enabling exceptional environments that benefit a large and growing aging population. Valued at $24.7 billion by market cap, the company owns seniors housing communities, skilled nursing facilities, hospitals, and medical office buildings in the U.S. and Canada. The leading healthcare REIT is expected to announce its fiscal fourth-quarter earnings for 2024 after the market closes on Wednesday, Feb. 12.
Ahead of the event, analysts expect VTR to report an FFO of $0.80 per share on a diluted basis, up 5.3% from $0.76 per share in the year-ago quarter. The company has beat or matched Wall Street’s FFO estimates in its last four quarterly reports.
For the full year, analysts expect VTR to report FFO of $3.16, up 5.7% from $2.99 in fiscal 2023. Its FFO is expected to rise 7.3% year over year to $3.39 in fiscal 2025.
VTR stock has underperformed the S&P 500’s ($SPX) 26.5% gains over the past 52 weeks, with shares up 22.7% during this period. However, it outperformed the Real Estate Select Sector SPDR Fund’s (XLRE) 6.5% gains over the same time frame.
On Oct. 30, VTR shares closed up marginally after reporting its Q3 results. Its FFO of $0.80 matched the analyst estimates. The company’s revenue was $1.24 billion, surpassing Wall Street forecasts of $1.21 billion. VTR expects full-year FFO in the range of $3.14 to $3.18.
Analysts’ consensus opinion on VTR stock is bullish, with a “Strong Buy” rating overall. Out of 19 analysts covering the stock, 13 advise a “Strong Buy” rating, two suggest a “Moderate Buy,” and four give a “Hold.” VTR’s average analyst price target is $70.50, indicating a potential upside of 19.7% from the current levels.
